Figure 4.
Figure 4. Antifibrinolytic treatment with ε-aminocaproic acid does not restore hemostasis in f5 mutants. Offspring from f5+/− incrosses were treated with ε-aminocaproic acid at 1 dpf and tested for venous occlusion in response to laser-mediated endothelial injury at 3 dpf, followed by genotyping. There was a slight increase in the percentage of f5−/− embryos that formed an occlusive thrombus (14.3% vs 5.5%) compared with untreated clutchmates, but this was not statistically significant. Horizontal bars represent the median time to occlusion. ns, not significant.

Antifibrinolytic treatment with ε-aminocaproic acid does not restore hemostasis in f5 mutants. Offspring from f5+/− incrosses were treated with ε-aminocaproic acid at 1 dpf and tested for venous occlusion in response to laser-mediated endothelial injury at 3 dpf, followed by genotyping. There was a slight increase in the percentage of f5−/− embryos that formed an occlusive thrombus (14.3% vs 5.5%) compared with untreated clutchmates, but this was not statistically significant. Horizontal bars represent the median time to occlusion. ns, not significant.

Close Modal

or Create an Account

Close Modal
Close Modal